Creative Planning
MRVI icon

Creative Planning’s Maravai LifeSciences MRVI Stock Holding History

Creative Planning’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$809K Buy
285,869
+61,504
+27% +$209K ﹤0.01% 2635
2025
Q4 		$729K Buy
224,365
+30,646
+16% +$103K ﹤0.01% 2530
2025
Q3 		$556K Buy
193,719
+77,688
+67% +$198K ﹤0.01% 2619
2025
Q2 		$280K Buy
116,031
+38,450
+50% +$80.8K ﹤0.01% 2957
2025
Q1 		$171K Buy
77,581
+43,039
+125% +$170K ﹤0.01% 3129
2024
Q4 		$188K Sell
34,542
-10,401
-23% -$66.9K ﹤0.01% 2990
2024
Q3 		$373K Buy
44,943
+1,881
+4% +$16.3K ﹤0.01% 2345
2024
Q2 		$308K Sell
43,062
-1,210
-3% -$10.4K ﹤0.01% 2322
2024
Q1 		$384K Buy
44,272
+5,446
+14% +$36.8K ﹤0.01% 2050
2023
Q4 		$254K Buy
38,826
+11,216
+41% +$72.5K ﹤0.01% 2215
2023
Q3 		$276K Buy
27,610
+9,165
+50% +$101K ﹤0.01% 2004
2023
Q2 		$229K Sell
18,445
-4,053
-18% -$54.7K ﹤0.01% 2117
2023
Q1 		$315K Buy
22,498
+4,662
+26% +$67K ﹤0.01% 1782
2022
Q4 		$255K Buy
17,836
+2,999
+20% +$47.2K ﹤0.01% 1834
2022
Q3 		$379K Sell
14,837
-57
-0.4% -$1.43K ﹤0.01% 1504
2022
Q2 		$423K Sell
14,894
-6,176
-29% -$196K ﹤0.01% 1406
2022
Q1 		$743K Buy
+21,070
New +$706K ﹤0.01% 1119

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's MRVI Position: Q1 2026 in Review

Creative Planning increased its Maravai LifeSciences (MRVI) stake by 27% in Q1 2026, buying an estimated $209K and bringing the position to 285,869 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Creative Planning first reported a position in MRVI in Q1 2022 and has held it in 17 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Creative Planning held 285,869 shares of Maravai LifeSciences worth $809K as of Q1 2026.
  • Creative Planning bought 61,504 Maravai LifeSciences shares in Q1 2026, an estimated $209K.
  • Maravai LifeSciences made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2635 holding.
  • Creative Planning first reported a position in Maravai LifeSciences in Q1 2022 and has held it in 17 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.